Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
56%
OVERLAP
BY WEIGHT
22
# OF OVERLAPPING
HOLDINGS
XLV
59
HOLDINGS
37%
ALSO IN HRTS
HRTS
45
HOLDINGS
49%
ALSO IN XLV
SECTOR DRIFT (XLV minus HRTS)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in HRTS |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 14.8% | 11.1% | 11.1% |
|
UNITEDHEALTH GROUP INC | 5.8% | 5.1% | 5.1% |
|
MERCK & CO. INC. | 6.0% | 4.4% | 4.4% |
|
JOHNSON & JOHNSON | 10.7% | 3.9% | 3.9% |
|
THERMO FISHER SCIENTIFIC INC | 3.8% | 5.2% | 3.8% |
XLV Overweight Relative to HRTS
|
JOHNSON & JOHNSON | 6.8% |
|
ABBVIE INC | 5.2% |
|
ELI LILLY & CO | 3.7% |
|
AMGEN INC | 2.7% |
|
PFIZER INC | 2.6% |
|
CVS CAREMARK CORP | 2.0% |
|
MERCK & CO. INC. | 1.6% |
|
ELEVANCE HEALTH INC | 1.5% |
|
CIGNA CORPORATION | 1.2% |
|
HCA HOLDINGS INC | 1.1% |
XLV Underweight Relative to HRTS
 |
NOVO NORDISK A/S-B | -4.7% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | -3.8% |
|
CYTOKINETICS INC | -3.8% |
|
REVOLUTION MEDICINES, INC. | -3.8% |
|
BRIDGEBIO PHARMA, INC. | -3.4% |
 |
ASTRAZENECA PLC | -2.9% |
|
NOVARTIS AG | -2.6% |
|
MADRIGAL PHARMACEUTICALS, INC. | -1.5% |
|
THERMO FISHER SCIENTIFIC INC | -1.4% |
|
ALNYLAM PHARMACEUTICALS INC | -1.2% |